Skip to main content

Advertisement

SpringerLink
Log in

Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Asian Perspective

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Data on quality of life (QOL) after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) is scarce in the Asian population. This study assesses QOL outcomes after CRS and HIPEC in an Asian cancer center.

Methods

Patients who completed CRS + HIPEC 6–18 months ago (27 patients) were enrolled in the study. QOL was measured via the European Organization for Research and Treatment of Cancer QLQ-C30 questionnaires. The scores were compared with a group of 393 disease-free cancer patients, not on active treatment, who had ECOG scores of either 0 or 1. The 1-sample t test was used to compare differences in QOL scores between the 2 groups.

Results

A total of 27 patients were analyzed, of which 22 (81 %) were females. Median age was 51 years (15–59 years). CRS + HIPEC were performed for ovarian cancer in 15 patients (55 %), appendiceal carcinoma in 5 patients (19 %), and colorectal carcinoma in 4 patients (15 %). The median intraoperative peritoneal carcinomatosis index (PCI) score was 15 (2–31) while the completeness of CC score was 0 and 1 in 25 and 2 patients, respectively. The median duration after CRS + HIPEC was 10 months (6–16 months). Global health status and functional and symptom scores were largely similar between patients after CRS + HIPEC and the control group. Cognitive functioning scores and fatigue scores were significantly better in the group after CRS + HIPEC (p = 0.014 and 0.04).

Conclusions

QOL after CRS and HIPEC can be equivalent to that of well-functioning, disease-free cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Stewart JH 4th, Shen P, Levine EA. Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol. 2005;12:765–77.

    Article  PubMed  Google Scholar 

  2. McQuellon RP, Russell GB, Shen P, et al. Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin. Ann Surg Oncol. 2008;15:125–33.

    Article  PubMed  Google Scholar 

  3. Verwaal VJ, Bruin S, Boot H, et al. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:2426–32.

    Article  PubMed  Google Scholar 

  4. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737–43.

    Article  PubMed  Google Scholar 

  5. Di Giorgio A, Naticchioni E, Biacchi D, et al. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer. 2008;113:315–25.

    Article  PubMed  Google Scholar 

  6. Yan TD, Welch L, Black D, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol. 2007;18:827–34.

    Article  PubMed  CAS  Google Scholar 

  7. Piso P, Glockzin G, von Breitenbuch P, et al. Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies. J Surg Oncol. 2009;100:317–20.

    Article  PubMed  Google Scholar 

  8. Poulin J, Deng R, Ingersoll TS, et al. Perceived family and friend support and the psychological well-being of American and Chinese elderly persons. J Cross Cult Gerontol. 2012;27:305–17.

    Article  PubMed  Google Scholar 

  9. Hill AR, McQuellon RP, Russell GB, et al. Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin. Ann Surg Oncol. 2011;18:3673–9.

    Article  PubMed  Google Scholar 

  10. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29–42.

    Article  PubMed  CAS  Google Scholar 

  11. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS, March 31, 2003.

  12. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.

    Article  PubMed  CAS  Google Scholar 

  13. Cheung YB, Thumboo J, Goh C, et al. The equivalence and difference between the English and Chinese versions of two major, cancer-specific, health-related quality-of-life questionnaires. Cancer. 2004;101:2874–80.

    Article  PubMed  Google Scholar 

  14. Fayers PM, Aaronson NK, Bjordal K, Curran D, Groenvold M. The EORTC QLQ-C30 Scoring Manual. 2nd ed. Brussels: European Organization for Research and Treatment of Cancer; 1999.

    Google Scholar 

  15. Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2009;7:5.

    Article  PubMed  Google Scholar 

  16. Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139–44.

    PubMed  CAS  Google Scholar 

  17. Tedeschi RG, Calhoun LG. The posttraumatic growth inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996;9:455–71.

    Article  PubMed  CAS  Google Scholar 

  18. Schmidt U, Dahlke MH, Klempnauer J, et al. Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 2005;31:53–8.

    Article  PubMed  CAS  Google Scholar 

  19. Alves S, Mohamed F, Yadegarfar G, et al. Prospective longitudinal study of quality of life following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Eur J Surg Oncol. 2010;36:1156–61.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank Professor Cheung Yin Bunn (Centre for Quantitative Medicine, Duke NUS, Singapore) for sharing his data and his experience in Quality of Life studies.

Disclosure

There are no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore

    Winson Jianhong Tan MBBS(Hons), MRCS, MMed, Joelle Fui Sze Wong MBBS, MRCS, Claramae Shulyn Chia MBBS, MRCS, MMed, FRCS, Grace Hwee Ching Tan MBBS, MRCS, Khee Chee Soo MBBS, MD, FRACS, FACS & Melissa Ching Ching Teo MBBS, FAMS, FRCS, MPH

Authors
  1. Winson Jianhong Tan MBBS(Hons), MRCS, MMed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joelle Fui Sze Wong MBBS, MRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Claramae Shulyn Chia MBBS, MRCS, MMed, FRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Grace Hwee Ching Tan MBBS, MRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Khee Chee Soo MBBS, MD, FRACS, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Melissa Ching Ching Teo MBBS, FAMS, FRCS, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Melissa Ching Ching Teo MBBS, FAMS, FRCS, MPH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tan, W.J., Wong, J.F.S., Chia, C.S. et al. Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Asian Perspective. Ann Surg Oncol 20, 4219–4223 (2013). https://doi.org/10.1245/s10434-013-3133-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-013-3133-0

Keywords

Search

Navigation